RecruitingNCT07334210

The Characteristics of Gut Microbiota in Patients With Sarcopenia and the Development of Probiotics

Sponsor

Seoul National University Bundang Hospital

Enrollment

150 participants

Start Date

Jun 13, 2025

Study Type

OBSERVATIONAL

Conditions

Sarcopenia

Summary

The primary aim of this study is to identify the composition and characteristics of the gut microbiota in patients with sarcopenia in older adults, and compare these with the gut microbiota characteristics of older adults and young control groups to determine differences. Secondary purpose of this study is to provide data on the characteristics of gut microbiota for the development of probiotics effective in treating sarcopenia in older adults.

Eligibility

Min Age: 20 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with sarcopenia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 20 Years to 90 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.